Market Cap 2.50B
Revenue (ttm) 1.41B
Net Income (ttm) -430.30M
EPS (ttm) N/A
PE Ratio 14.78
Forward PE 13.19
Profit Margin -30.60%
Debt to Equity Ratio 8.39
Volume 270,492
Avg Vol 307,458
Day's Range N/A - N/A
Shares Out 35.96M
Stochastic %K 92%
Beta 1.36
Analysts Strong Sell
Price Target $69.50

Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 843 740 2300
Address:
4920 O'Hear Avenue, Suite 400, North Charleston, United States
ZacksResearch
ZacksResearch Jan. 15 at 2:22 PM
$NGVT is quietly ripping — up 18.7% in just three months. 🔥 Shares are climbing as asset divestitures and accretive acquisitions sharpen the company’s focus, improve margins, and restore investor confidence. See what’s driving the momentum in NGVT 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-teaser-29015&ADID=SYND_STOCKTWITS_TWEET_2_2817854_TEASER_29015
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 1:22 PM
$NGVT up 18.7% in 3 months — what's driving this rally? 🚀 🔍 Strategic divestiture and acquisitions boost margins 💼 Sale of CTO assets for $110M plus contingent consideration fuels portfolio focus 📈 Growth in construction & infrastructure markets via Ozark Materials buy Discover more about this upward momentum 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-body-28998&ADID=SYND_STOCKTWITS_TWEET_2_2817854_BODY_28998
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 4:18 PM
$NGVT cleans house — $110M cash deal to sharpen the focus ⚡ Ingevity completed a $110M all-cash sale of its North Charleston CTO refinery assets, streamlining operations and doubling down on higher-margin specialties. See what this strategic shift means next 👉 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-teaser-27541&ADID=SYND_STOCKTWITS_TWEET_2_2812650_TEASER_27541
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 3:18 PM
$NGVT reshapes portfolio with $110M divestiture! 🚀 By selling its North Charleston CTO assets, Ingevity sharpens focus on high-margin specialty applications. Shares up 57.9% over the past year — a strategic pivot paying off. See why this matters for investors 👇 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-body-27539&ADID=SYND_STOCKTWITS_TWEET_2_2812650_BODY_27539
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:10 PM
🔥 $NGVT is up 27% in just six months — and this move isn’t random. The rally is being driven by value-creating acquisitions, portfolio optimization, and long-term growth initiatives, all pushing the stock higher over the past half-year. 📈 What’s really fueling the momentum? Full breakdown here 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-teaser-27124&ADID=SYND_STOCKTWITS_TWEET_2_2811302_TEASER_27124
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 3:10 PM
$NGVT's 26.6% share gain over the past six months — what's driving the momentum? 🔥 🚀 Strategic acquisitions boosting margins 📈 Exit from low-margin markets enhancing cash flow 📊 Long-term growth supported by capacity expansions See why NGVT might keep climbing 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-body-27123&ADID=SYND_STOCKTWITS_TWEET_2_2811302_BODY_27123
0 · Reply
GenomicsGlow
GenomicsGlow Dec. 27 at 4:19 PM
$NGVT Valuation sensitivity is high because visibility is uneven; customer retention trends will be critical to monitor — measurable traction would outweigh rhetoric. From here, results — not promises — will decide direction.
0 · Reply
Estimize
Estimize Dec. 22 at 12:00 PM
Wall St is expecting 0.69 EPS for $NGVT Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/ngvt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 2:35 PM
Wells Fargo has updated their rating for Ingevity ( $NGVT ) to Equal-Weight with a price target of 60.
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 12:57 PM
BMO Capital has updated their rating for Ingevity ( $NGVT ) to Outperform with a price target of 70.
0 · Reply
Latest News on NGVT
Ingevity announces key leadership transitions

Dec 8, 2025, 6:30 AM EST - 7 weeks ago

Ingevity announces key leadership transitions


Ingevity Corporation (NGVT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 2:16 PM EST - 2 months ago

Ingevity Corporation (NGVT) Q3 2025 Earnings Call Transcript


Ingevity reports third quarter 2025 financial results

Nov 5, 2025, 4:15 PM EST - 2 months ago

Ingevity reports third quarter 2025 financial results


Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:30 PM EDT - 6 months ago

Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript


Ingevity reports second quarter 2025 financial results

Aug 4, 2025, 4:15 PM EDT - 6 months ago

Ingevity reports second quarter 2025 financial results


Ingevity named one of America's Best Mid-sized Companies by TIME

Jul 22, 2025, 11:00 AM EDT - 6 months ago

Ingevity named one of America's Best Mid-sized Companies by TIME


Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript

May 6, 2025, 12:45 PM EDT - 9 months ago

Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript


Ingevity reports first quarter 2025 financial results

May 5, 2025, 4:15 PM EDT - 9 months ago

Ingevity reports first quarter 2025 financial results


Ingevity announces appointment of David H. Li as president and CEO

Mar 10, 2025, 4:15 PM EDT - 11 months ago

Ingevity announces appointment of David H. Li as president and CEO


Ingevity Corporation (NGVT) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 12:31 PM EST - 1 year ago

Ingevity Corporation (NGVT) Q4 2024 Earnings Call Transcript


Ingevity elects Kevin Willis to its board of directors

Dec 16, 2024, 4:15 PM EST - 1 year ago

Ingevity elects Kevin Willis to its board of directors


Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:21 PM EDT - 1 year ago

Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript


Ingevity reports third quarter 2024 financial results

Oct 29, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports third quarter 2024 financial results


Ingevity Corporation (NGVT) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 3:26 PM EDT - 1 year ago

Ingevity Corporation (NGVT) Q2 2024 Earnings Call Transcript


Ingevity reports second quarter 2024 financial results

Jul 31, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports second quarter 2024 financial results


Ingevity Corporation (NGVT) Q1 2024 Earnings Call Transcript

May 4, 2024, 2:16 PM EDT - 1 year ago

Ingevity Corporation (NGVT) Q1 2024 Earnings Call Transcript


Ingevity reports first quarter 2024 financial results

May 1, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports first quarter 2024 financial results


ZacksResearch
ZacksResearch Jan. 15 at 2:22 PM
$NGVT is quietly ripping — up 18.7% in just three months. 🔥 Shares are climbing as asset divestitures and accretive acquisitions sharpen the company’s focus, improve margins, and restore investor confidence. See what’s driving the momentum in NGVT 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-teaser-29015&ADID=SYND_STOCKTWITS_TWEET_2_2817854_TEASER_29015
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 1:22 PM
$NGVT up 18.7% in 3 months — what's driving this rally? 🚀 🔍 Strategic divestiture and acquisitions boost margins 💼 Sale of CTO assets for $110M plus contingent consideration fuels portfolio focus 📈 Growth in construction & infrastructure markets via Ozark Materials buy Discover more about this upward momentum 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-body-28998&ADID=SYND_STOCKTWITS_TWEET_2_2817854_BODY_28998
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 4:18 PM
$NGVT cleans house — $110M cash deal to sharpen the focus ⚡ Ingevity completed a $110M all-cash sale of its North Charleston CTO refinery assets, streamlining operations and doubling down on higher-margin specialties. See what this strategic shift means next 👉 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-teaser-27541&ADID=SYND_STOCKTWITS_TWEET_2_2812650_TEASER_27541
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 3:18 PM
$NGVT reshapes portfolio with $110M divestiture! 🚀 By selling its North Charleston CTO assets, Ingevity sharpens focus on high-margin specialty applications. Shares up 57.9% over the past year — a strategic pivot paying off. See why this matters for investors 👇 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-body-27539&ADID=SYND_STOCKTWITS_TWEET_2_2812650_BODY_27539
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:10 PM
🔥 $NGVT is up 27% in just six months — and this move isn’t random. The rally is being driven by value-creating acquisitions, portfolio optimization, and long-term growth initiatives, all pushing the stock higher over the past half-year. 📈 What’s really fueling the momentum? Full breakdown here 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-teaser-27124&ADID=SYND_STOCKTWITS_TWEET_2_2811302_TEASER_27124
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 3:10 PM
$NGVT's 26.6% share gain over the past six months — what's driving the momentum? 🔥 🚀 Strategic acquisitions boosting margins 📈 Exit from low-margin markets enhancing cash flow 📊 Long-term growth supported by capacity expansions See why NGVT might keep climbing 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-body-27123&ADID=SYND_STOCKTWITS_TWEET_2_2811302_BODY_27123
0 · Reply
GenomicsGlow
GenomicsGlow Dec. 27 at 4:19 PM
$NGVT Valuation sensitivity is high because visibility is uneven; customer retention trends will be critical to monitor — measurable traction would outweigh rhetoric. From here, results — not promises — will decide direction.
0 · Reply
Estimize
Estimize Dec. 22 at 12:00 PM
Wall St is expecting 0.69 EPS for $NGVT Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/ngvt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 2:35 PM
Wells Fargo has updated their rating for Ingevity ( $NGVT ) to Equal-Weight with a price target of 60.
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 12:57 PM
BMO Capital has updated their rating for Ingevity ( $NGVT ) to Outperform with a price target of 70.
0 · Reply
Estimize
Estimize Nov. 27 at 9:00 PM
Wall St is expecting 0.74 EPS for $NGVT Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/ngvt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 3:22 PM
Wells Fargo updates rating for Ingevity ( $NGVT ) to Equal-Weight, target set at 52 → 55.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 10 at 7:10 PM
$NGVT Share Price: $49.53 Contract Selected: Apr 17, 2026 $60 Calls Buy Zone: $1.23 – $1.52 Target Zone: $2.26 – $2.76 Potential Upside: 73% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
d_risk
d_risk Nov. 7 at 12:19 AM
$NGVT - Ingevity Corporation Common Stock - 10Q - Updated Risk Factors NGVT flags heightened risks from new U.S.-China tariffs threatening export margins, and warns of increased vulnerability to operational disruptions from labor issues, supply chain dependencies, and post-divestiture changes. #ChemicalsIndustry #Post-DivestitureImpact #LaborDisruptions #SupplyChainRisk #TradeTariffs 🟢 Added 🟠 Removed https://d-risk.ai/NGVT/10-Q/2025-11-06
0 · Reply
JackDarwin
JackDarwin Nov. 6 at 1:15 PM
$NGVT Bullish Tweezer + Bullish Engulfing Candlestick Pattern at Downtrend
0 · Reply
SignalRange
SignalRange Oct. 5 at 1:41 PM
$NGVT Industrial technology consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 10:34 AM
$NGVT Excellent article that nails exactly where NGVT stands right now. So if you want to update your NGVT knowledge or get acquainted with NGVT, this is a must read. https://beyondspx.com/quote/NGVT/analysis/ingevity-s-strategic-rebirth-unlocking-value-through-portfolio-optimization-and-core-strengths-nyse-ngvt
0 · Reply
ZacksResearch
ZacksResearch Sep. 8 at 5:24 PM
$NGVT cashes in with $110M deal 💰 Selling its North Charleston CTO refinery and most specialty lines to Mainstream sharpens the company’s focus. Deal details here 👉 https://www.zacks.com/stock/news/2748097/ngvt-agrees-to-divest-north-charleston-cto-refinery-to-mainstream-pine?cid=sm-stocktwits-2-2748097-teaser-11411&ADID=SYND_STOCKTWITS_TWEET_2_2748097_TEASER_11411
0 · Reply
ZacksResearch
ZacksResearch Sep. 8 at 4:24 PM
$NGVT sees strategic shift with asset divestiture — what's the impact? 🤔 Ingevity is selling its North Charleston CTO refinery assets, expecting $110M in cash proceeds to boost margins and cash flow flexibility. The move aligns with its strategy to reduce portfolio volatility and enhance strategic options. The transaction is expected to close by early 2026. 📈 Full insights on NGVT's move here 👉 https://www.zacks.com/stock/news/2748097/ngvt-agrees-to-divest-north-charleston-cto-refinery-to-mainstream-pine?cid=sm-stocktwits-2-2748097-body-11388&ADID=SYND_STOCKTWITS_TWEET_2_2748097_BODY_11388
0 · Reply